Confirm Your State Isn't One of the Four Excluded Prescription medication available only after consultation and approval by a licensed healthcare provider, if clinically appropriate
Frequently Asked Questions Is GLP-1 microdosing considered off-label use
No pause: excluded those with pauses in metformin, SGLT2 inhibitor or GLP-1 receptor agonist during the study period
In addition, studies have shown that it also has a certain protective effect on reducing the incidence of cardiovascular disease in some high-risk groups
In clinical trials, retatrutide has been administered via subcutaneous injection on a once-weekly basis, with doses escalating gradually over several weeks to improve tolerability
* Correspondence: Aleksandra Jdrasek, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers